<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>!&quot;#$%!&amp;%##&amp;'()*+,-.&amp;/01*-0)*,(&amp;%,2345()</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="408" left="95" width="211" height="12" font="1">Stimulates transcription from the HSP70 promoter.</text>
<text top="597" left="238" width="188" height="12" font="1">http://www.sigmaaldrich.com/catalog/Produ</text>
<text top="607" left="238" width="188" height="12" font="1">ctDetail.do?D7=0&amp;N5=SEARCH_CONCAT_PN</text>
<text top="617" left="238" width="185" height="12" font="1">O%7CBRAND_KEY&amp;N4=SAB2100398%7CSIG</text>
<text top="627" left="238" width="123" height="12" font="1">MA&amp;N25=0&amp;QS=ON&amp;F=SPEC</text>
<text top="78" left="138" width="38" height="12" font="1">10/28/11</text>
<text top="336" left="95" width="372" height="12" font="1">immunogen sequenceKDNASLKQLRWEAERDDWLHNRDAKSIIKKKKHFKKKRIKTTQKTKKQRK</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="215" left="121" width="50" height="12" font="1">Anti-CEBPZ </text>
<text top="215" left="339" width="122" height="12" font="1">CEBPZ  (EntrezGeneID 10153)</text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="26" height="12" font="1">Sigma</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="33" height="12" font="1">QC8343</text>
<text top="300" left="215" width="52" height="12" font="1">SAB2100398</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="39" left="125" width="426" height="12" font="1">Comment: We observe one major band consistent with the expected size of CEBPZ (121kD) in cell lines</text>
<text top="49" left="125" width="409" height="12" font="1">GM12878, K562, HeLa S3, and HepG2.  This band is specifically immunoprecipitated with moderate</text>
<text top="59" left="125" width="419" height="12" font="1">efficiency (note presence of some material in unbound fration (lane 2)) from K562 cells, with no other</text>
<text top="69" left="125" width="416" height="12" font="1">bands visibly immunoprecipitated.  Additionally,  we performed mass spectrometry analysis on both</text>
<text top="79" left="125" width="410" height="12" font="1">bands immunoprecipitated from K562 and identified Maz as a major component of each band (see</text>
<text top="89" left="125" width="302" height="12" font="1">validation #2).  Therefore, SAB2100398 meets this criterion for validation.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="22" family="Times" color="#000000"/>
	<fontspec id="4" size="8" family="Times" color="#000000"/>
	<fontspec id="5" size="26" family="Times" color="#000000"/>
	<fontspec id="6" size="10" family="Times" color="#000000"/>
<text top="312" left="560" width="8" height="11" font="1">3 </text>
<text top="312" left="492" width="28" height="11" font="1">Lane: </text>
<text top="184" left="493" width="42" height="11" font="1">MW (kD) </text>
<text top="221" left="503" width="19" height="11" font="1">150 </text>
<text top="239" left="503" width="19" height="11" font="1">100 </text>
<text top="250" left="506" width="14" height="11" font="1">75 </text>
<text top="266" left="506" width="14" height="11" font="1">50 </text>
<text top="206" left="503" width="19" height="11" font="1">250 </text>
<text top="281" left="506" width="14" height="11" font="1">38 </text>
<text top="312" left="526" width="24" height="11" font="1">1  2 </text>
<text top="312" left="591" width="8" height="11" font="1">4 </text>
<text top="186" left="451" width="29" height="27" font="3">B. </text>
<text top="402" left="72" width="653" height="11" font="4"><b>A.</b>  Western blot using SAB2100398. Lanes contain nuclear lysates from GM12878 cells (Lane 1), K562 cells (Lane 2), HeLa S3 cells (Lane 3), and </text>
<text top="414" left="72" width="635" height="11" font="1">HepG2 cells (Lane 4).   <b>B.  </b>Immunoprecipitation of CEBPZ from K562 cells using SAB2100398.  Lane 1: input nuclear lysate, Lane 2:  unbound </text>
<text top="426" left="72" width="634" height="11" font="1">material from immunoprecipitation with ab87525, Lane 3: material immunoprecipitated with ab9263, Lane 4: material immunoprecipitated using </text>
<text top="438" left="72" width="60" height="11" font="1">control IgG.   </text>
<text top="63" left="282" width="300" height="31" font="5">SAB2100398 (CEBPZ)  </text>
<text top="96" left="222" width="412" height="31" font="5">Immunoblot/immunoprecipitation </text>
<text top="130" left="418" width="7" height="27" font="3"> </text>
<text top="337" left="215" width="89" height="11" font="1">  Lane   1    2    3   4</text>
<text top="335" left="304" width="7" height="13" font="6"><b>  </b></text>
<text top="218" left="231" width="19" height="11" font="1">150 </text>
<text top="235" left="231" width="19" height="11" font="1">100 </text>
<text top="248" left="234" width="14" height="11" font="1">75 </text>
<text top="266" left="234" width="14" height="11" font="1">50 </text>
<text top="200" left="231" width="19" height="11" font="1">250 </text>
<text top="298" left="234" width="14" height="11" font="1">25 </text>
<text top="184" left="221" width="42" height="11" font="1">MW (kD) </text>
<text top="186" left="171" width="29" height="27" font="3">A. </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="696" left="268" width="68" height="12" font="1">Submit by Email</text>
<text top="39" left="130" width="418" height="12" font="1">Immunoprecipitation of CEBPZ from K562 cells using SAB2100398.  Lane 1: input nuclear lysate, Lane</text>
<text top="49" left="130" width="407" height="12" font="1">2: material immunoprecipitated with ab87525, Lane 3: material immunoprecipitated using control</text>
<text top="59" left="130" width="381" height="12" font="1">IgG.  Bands A and B were excised from the gel and subject to analysis by mass spectrometry.</text>
<text top="79" left="130" width="406" height="12" font="1">IP followed by mass spectrometry: Briefly, K562 whole cell lysates were immunoprecipitated using</text>
<text top="89" left="130" width="412" height="12" font="1">SAB2100398, and the IP fraction was loaded on a 10% polyacrylamide gel (NuPAGE Bis-Tris Gel) and</text>
<text top="99" left="130" width="383" height="12" font="1">separated with an invitrogen NuPAGE electrophoresis system. The gel was silver-stained, gel</text>
<text top="109" left="130" width="408" height="12" font="1">fragments corresponding to the bands indicated were excised and destained using the SilverSNAP</text>
<text top="119" left="130" width="423" height="12" font="1">Stain for Mass Spectrometry (Pierce). Then proteins were trysinized using the in-gel digestion method.</text>
<text top="129" left="130" width="412" height="12" font="1">Digested proteins were analyzed on an LTQ-Orbitrap (Thermo Scientific) by the  nanoLC-ESI-MS/MS</text>
<text top="139" left="130" width="409" height="12" font="1">technique. Peptides were identified by  the SEQUEST algorithm and filtered with a high confidence</text>
<text top="149" left="130" width="325" height="12" font="1">threshold (Protein false discovery rate &lt; 1%, 2 peptides per protein minimum).</text>
<text top="169" left="130" width="418" height="12" font="1">We report only 4 proteins identified in band A, where the majority of signal detected by Western blot</text>
<text top="179" left="130" width="361" height="12" font="1">is located.  CEBPZ is the most abundant of these (14 peptides) and is the only predicted</text>
<text top="189" left="130" width="369" height="12" font="1">sequence-specific DNA-binding protein.   We also note that CEBPZ is found in the control</text>
<text top="199" left="130" width="421" height="12" font="1">immunoprecipitation, but CEBPZ is known to be abundant and is present at much higher levels in the</text>
<text top="209" left="130" width="405" height="12" font="1">specific immunoprecipitation relative to the control (3.5 fold enrichment; in comparison the other</text>
<text top="219" left="130" width="378" height="12" font="1">two proteins identified in this band from both samples are 4-13 fold enriched in the control</text>
<text top="229" left="130" width="94" height="12" font="1">immunoprecipitation).</text>
<text top="249" left="130" width="420" height="12" font="1">We also tested a lower band which contained a minor fraction of the signal seen in the Western blots.</text>
<text top="259" left="130" width="418" height="12" font="1">We identify 89 proteins in band B and CEBPZ was the third most abundant of these (15 peptides) and</text>
<text top="269" left="130" width="337" height="12" font="1">the most abundant protein highly enriched in the specific immunoprecipitation.  </text>
<text top="289" left="130" width="404" height="12" font="1">Based on these observations, all major bands are likely due to the presence of immunoprecipated</text>
<text top="299" left="130" width="347" height="12" font="1">CEBPZ and SAB2100398 meets the ENCODE standard for validation by this criterion.</text>
</page>
<page number="5" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="7" size="14" family="Times" color="#000000"/>
	<fontspec id="8" size="10" family="Times" color="#000000"/>
<text top="207" left="167" width="32" height="20" font="7">MW </text>
<text top="237" left="170" width="28" height="20" font="7">250 </text>
<text top="264" left="170" width="28" height="20" font="7">150 </text>
<text top="285" left="170" width="28" height="20" font="7">100 </text>
<text top="305" left="178" width="20" height="20" font="7">75 </text>
<text top="333" left="169" width="31" height="20" font="7">   50 </text>
<text top="355" left="179" width="20" height="20" font="7">37 </text>
<text top="379" left="179" width="20" height="20" font="7">25 </text>
<text top="418" left="178" width="20" height="20" font="7">10 </text>
<text top="475" left="178" width="34" height="20" font="7">Lane </text>
<text top="475" left="244" width="118" height="20" font="7">1             2            3 </text>
<text top="386" left="467" width="187" height="15" font="8">Lane 1 Input lysate from cell line K562 </text>
<text top="400" left="467" width="3" height="15" font="8"> </text>
<text top="414" left="467" width="151" height="15" font="8">Lane 2 Bound material from IP </text>
<text top="429" left="467" width="3" height="15" font="8"> </text>
<text top="443" left="467" width="209" height="15" font="8">Lane 3 Bound material from IP            using </text>
<text top="458" left="521" width="78" height="15" font="8">non‐speciﬁc IgG</text>
<text top="454" left="599" width="4" height="20" font="7"> </text>
<text top="267" left="394" width="50" height="20" font="7">Band A </text>
<text top="337" left="393" width="49" height="20" font="7">Band B </text>
<text top="73" left="247" width="293" height="31" font="5">SAB2100398 (CEBPZ)  </text>
<text top="106" left="145" width="496" height="31" font="5">Immunoprecipitation/Mass spectrometry</text>
<text top="110" left="635" width="7" height="27" font="3"> </text>
<text top="140" left="43" width="7" height="27" font="3"> </text>
</page>
<page number="6" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="9" size="9" family="Times" color="#000000"/>
<text top="72" left="56" width="34" height="13" font="9">Spectra</text>
<text top="72" left="140" width="74" height="13" font="9">Name of Protein</text>
<text top="72" left="485" width="233" height="13" font="9">Count of Peptides PeptideRatio(CEBPZ/IgG control)</text>
<text top="86" left="56" width="65" height="13" font="9">CEBPZ_Band A</text>
<text top="86" left="140" width="167" height="13" font="9">CCAAT/enhancer‐binding protein zeta</text>
<text top="86" left="553" width="11" height="13" font="9">14</text>
<text top="86" left="704" width="14" height="13" font="9">3.5</text>
<text top="100" left="56" width="65" height="13" font="9">CEBPZ_Band A</text>
<text top="100" left="140" width="138" height="13" font="9">ATP‐dependent RNA helicase A</text>
<text top="100" left="559" width="6" height="13" font="9">3</text>
<text top="100" left="659" width="59" height="13" font="9">0.076923077</text>
<text top="114" left="56" width="65" height="13" font="9">CEBPZ_Band A</text>
<text top="114" left="140" width="128" height="13" font="9">FACT complex subunit SPT16</text>
<text top="114" left="559" width="6" height="13" font="9">3</text>
<text top="114" left="659" width="59" height="13" font="9">0.230769231</text>
<text top="128" left="56" width="65" height="13" font="9">CEBPZ_Band A</text>
<text top="128" left="140" width="263" height="13" font="9">Deoxynucleotidyltransferase terminal‐interacting protein 2</text>
<text top="128" left="559" width="6" height="13" font="9">2</text>
<text top="128" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="142" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="142" left="140" width="105" height="13" font="9">Isoform A of Lamin‐A/C</text>
<text top="142" left="553" width="11" height="13" font="9">19</text>
<text top="142" left="712" width="6" height="13" font="9">2</text>
<text top="156" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="156" left="140" width="190" height="13" font="9">ATP synthase subunit alpha, mitochondrial</text>
<text top="156" left="553" width="11" height="13" font="9">18</text>
<text top="156" left="712" width="6" height="13" font="9">8</text>
<text top="170" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="170" left="140" width="167" height="13" font="9">CCAAT/enhancer‐binding protein zeta</text>
<text top="170" left="553" width="11" height="13" font="9">15</text>
<text top="170" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="184" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="184" left="140" width="92" height="13" font="9">Nucleolar protein 58</text>
<text top="184" left="553" width="11" height="13" font="9">15</text>
<text top="184" left="659" width="59" height="13" font="9">0.789473684</text>
<text top="198" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="198" left="140" width="195" height="13" font="9">Heterogeneous nuclear ribonucleoprotein L</text>
<text top="198" left="553" width="11" height="13" font="9">13</text>
<text top="198" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="211" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="211" left="140" width="253" height="13" font="9">Isoform 1 of Heterogeneous nuclear ribonucleoprotein R</text>
<text top="211" left="553" width="11" height="13" font="9">13</text>
<text top="211" left="712" width="6" height="13" font="9">2</text>
<text top="225" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="225" left="140" width="241" height="13" font="9">h/ACA ribonucleoprotein complex subunit 4 isoform 2</text>
<text top="225" left="553" width="11" height="13" font="9">11</text>
<text top="225" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="239" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="239" left="140" width="98" height="13" font="9">Histone deacetylase 1</text>
<text top="239" left="553" width="11" height="13" font="9">10</text>
<text top="239" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="253" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="253" left="140" width="231" height="13" font="9">Insulin‐like growth factor 2 mRNA‐binding protein 1</text>
<text top="253" left="553" width="11" height="13" font="9">10</text>
<text top="253" left="659" width="59" height="13" font="9">0.769230769</text>
<text top="267" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="267" left="140" width="185" height="13" font="9">ATP synthase subunit beta, mitochondrial</text>
<text top="267" left="553" width="11" height="13" font="9">10</text>
<text top="267" left="704" width="14" height="13" font="9">2.5</text>
<text top="281" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="281" left="140" width="197" height="13" font="9">Heterogeneous nuclear ribonucleoprotein H</text>
<text top="281" left="553" width="11" height="13" font="9">10</text>
<text top="281" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="295" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="295" left="140" width="199" height="13" font="9">Probable ATP‐dependent RNA helicase DDX5</text>
<text top="295" left="559" width="6" height="13" font="9">9</text>
<text top="295" left="712" width="6" height="13" font="9">1</text>
<text top="309" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="309" left="140" width="196" height="13" font="9">Heterogeneous nuclear ribonucleoprotein K</text>
<text top="309" left="559" width="6" height="13" font="9">8</text>
<text top="309" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="323" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="323" left="140" width="92" height="13" font="9">Nucleolar protein 56</text>
<text top="323" left="559" width="6" height="13" font="9">8</text>
<text top="323" left="659" width="59" height="13" font="9">3.416666667</text>
<text top="337" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="337" left="140" width="140" height="13" font="9">Pre‐mRNA‐processing factor 19</text>
<text top="337" left="559" width="6" height="13" font="9">8</text>
<text top="337" left="712" width="6" height="13" font="9">8</text>
<text top="351" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="351" left="140" width="144" height="13" font="9">Eukaryotic initiation factor 4A‐III</text>
<text top="351" left="559" width="6" height="13" font="9">8</text>
<text top="351" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="365" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="365" left="140" width="189" height="13" font="9">Putative uncharacterized protein HNRNPD</text>
<text top="365" left="559" width="6" height="13" font="9">8</text>
<text top="365" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="379" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="379" left="140" width="138" height="13" font="9">ATP‐dependent RNA helicase A</text>
<text top="379" left="559" width="6" height="13" font="9">7</text>
<text top="379" left="659" width="59" height="13" font="9">0.583333333</text>
<text top="392" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="392" left="140" width="303" height="13" font="9">cDNA FLJ45706 fis, clone FEBRA2028457, highly similar to Nucleolin</text>
<text top="392" left="559" width="6" height="13" font="9">7</text>
<text top="392" left="659" width="59" height="13" font="9">1.714285714</text>
<text top="406" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="406" left="140" width="98" height="13" font="9">Histone deacetylase 2</text>
<text top="406" left="559" width="6" height="13" font="9">7</text>
<text top="406" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="420" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="420" left="140" width="195" height="13" font="9">Isoform 2 of Putative oxidoreductase GLYR1</text>
<text top="420" left="559" width="6" height="13" font="9">7</text>
<text top="420" left="704" width="14" height="13" font="9">1.4</text>
<text top="434" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="434" left="140" width="69" height="13" font="9">RSL1D1 protein</text>
<text top="434" left="559" width="6" height="13" font="9">7</text>
<text top="434" left="704" width="14" height="13" font="9">3.5</text>
<text top="448" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="448" left="140" width="122" height="13" font="9">Splicing factor 3A subunit 3</text>
<text top="448" left="559" width="6" height="13" font="9">7</text>
<text top="448" left="712" width="6" height="13" font="9">3</text>
<text top="462" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="462" left="140" width="144" height="13" font="9">Stress‐70 protein, mitochondrial</text>
<text top="462" left="559" width="6" height="13" font="9">7</text>
<text top="462" left="692" width="25" height="13" font="9">0.875</text>
<text top="476" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="476" left="140" width="259" height="13" font="9">cDNA FLJ58049, highly similar to RNA‐binding protein FUS</text>
<text top="476" left="559" width="6" height="13" font="9">6</text>
<text top="476" left="659" width="59" height="13" font="9">1.714285714</text>
<text top="490" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="490" left="140" width="83" height="13" font="9">Isoform 1 of Cirhin</text>
<text top="490" left="559" width="6" height="13" font="9">6</text>
<text top="490" left="659" width="59" height="13" font="9">0.857142857</text>
<text top="504" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="504" left="140" width="255" height="13" font="9">Isoform 2 of Heterogeneous nuclear ribonucleoprotein Q</text>
<text top="504" left="559" width="6" height="13" font="9">6</text>
<text top="504" left="712" width="6" height="13" font="9">1</text>
<text top="518" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="518" left="140" width="255" height="13" font="9">Isoform 4 of Heterogeneous nuclear ribonucleoprotein Q</text>
<text top="518" left="559" width="6" height="13" font="9">6</text>
<text top="518" left="704" width="14" height="13" font="9">1.2</text>
</page>
<page number="7" position="absolute" top="0" left="0" height="612" width="792">
<text top="72" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="72" left="140" width="270" height="13" font="9">Isoform Long of Heterogeneous nuclear ribonucleoprotein U</text>
<text top="72" left="559" width="6" height="13" font="9">6</text>
<text top="72" left="712" width="6" height="13" font="9">2</text>
<text top="86" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="86" left="140" width="42" height="13" font="9">Lamin‐B2</text>
<text top="86" left="559" width="6" height="13" font="9">6</text>
<text top="86" left="712" width="6" height="13" font="9">1</text>
<text top="100" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="100" left="140" width="246" height="13" font="9">U3 small nucleolar RNA‐associated protein 18 homolog</text>
<text top="100" left="559" width="6" height="13" font="9">6</text>
<text top="100" left="712" width="6" height="13" font="9">1</text>
<text top="114" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="114" left="140" width="241" height="13" font="9">U3 small nucleolar RNA‐associated protein 6 homolog</text>
<text top="114" left="559" width="6" height="13" font="9">6</text>
<text top="114" left="659" width="59" height="13" font="9">0.666666667</text>
<text top="128" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="128" left="140" width="200" height="13" font="9">U3 small nucleolar RNA‐interacting protein 2</text>
<text top="128" left="559" width="6" height="13" font="9">6</text>
<text top="128" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="142" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="142" left="140" width="226" height="13" font="9">Zinc finger protein with KRAB and SCAN domains 4</text>
<text top="142" left="559" width="6" height="13" font="9">6</text>
<text top="142" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="156" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="156" left="140" width="162" height="13" font="9">ATP‐dependent RNA helicase DDX39</text>
<text top="156" left="559" width="6" height="13" font="9">6</text>
<text top="156" left="712" width="6" height="13" font="9">6</text>
<text top="170" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="170" left="140" width="259" height="13" font="9">cDNA FLJ50996, highly similar to 60S ribosomal protein L4</text>
<text top="170" left="559" width="6" height="13" font="9">6</text>
<text top="170" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="184" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="184" left="140" width="167" height="13" font="9">DDB1‐ and CUL4‐associated factor 13</text>
<text top="184" left="559" width="6" height="13" font="9">6</text>
<text top="184" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="198" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="198" left="140" width="196" height="13" font="9">Heterogeneous nuclear ribonucleoprotein F</text>
<text top="198" left="559" width="6" height="13" font="9">6</text>
<text top="198" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="211" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="211" left="140" width="197" height="13" font="9">Heterogeneous nuclear ribonucleoprotein G</text>
<text top="211" left="559" width="6" height="13" font="9">6</text>
<text top="211" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="225" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="225" left="140" width="169" height="13" font="9">Nucleolar complex protein 4 homolog</text>
<text top="225" left="559" width="6" height="13" font="9">6</text>
<text top="225" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="239" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="239" left="140" width="243" height="13" font="9">Isoform 2 of Guanine nucleotide‐binding protein‐like 3</text>
<text top="239" left="559" width="6" height="13" font="9">5</text>
<text top="239" left="712" width="6" height="13" font="9">1</text>
<text top="253" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="253" left="140" width="262" height="13" font="9">Isoform 3 of Probable ATP‐dependent RNA helicase DDX17</text>
<text top="253" left="559" width="6" height="13" font="9">5</text>
<text top="253" left="659" width="59" height="13" font="9">1.666666667</text>
<text top="267" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="267" left="140" width="317" height="13" font="9">Putative pre‐mRNA‐splicing factor ATP‐dependent RNA helicase DHX15</text>
<text top="267" left="559" width="6" height="13" font="9">5</text>
<text top="267" left="659" width="59" height="13" font="9">1.666666667</text>
<text top="281" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="281" left="140" width="246" height="13" font="9">U3 small nucleolar RNA‐associated protein 15 homolog</text>
<text top="281" left="559" width="6" height="13" font="9">5</text>
<text top="281" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="295" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="295" left="140" width="179" height="13" font="9">Cell growth‐regulating nucleolar protein</text>
<text top="295" left="559" width="6" height="13" font="9">5</text>
<text top="295" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="309" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="309" left="140" width="86" height="13" font="9">Isoform 1 of Erlin‐2</text>
<text top="309" left="559" width="6" height="13" font="9">5</text>
<text top="309" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="323" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="323" left="140" width="77" height="13" font="9">Lamin‐B receptor</text>
<text top="323" left="559" width="6" height="13" font="9">5</text>
<text top="323" left="712" width="6" height="13" font="9">5</text>
<text top="337" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="337" left="140" width="250" height="13" font="9">probable ATP‐dependent RNA helicase DDX47 isoform 2</text>
<text top="337" left="559" width="6" height="13" font="9">5</text>
<text top="337" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="351" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="351" left="140" width="221" height="13" font="9">Ribosome biogenesis regulatory protein homolog</text>
<text top="351" left="559" width="6" height="13" font="9">5</text>
<text top="351" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="365" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="365" left="140" width="66" height="13" font="9">59 kDa protein</text>
<text top="365" left="559" width="6" height="13" font="9">4</text>
<text top="365" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="379" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="379" left="140" width="185" height="13" font="9">60 kDa heat shock protein, mitochondrial</text>
<text top="379" left="559" width="6" height="13" font="9">4</text>
<text top="379" left="659" width="59" height="13" font="9">0.571428571</text>
<text top="392" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="392" left="140" width="169" height="13" font="9">Isoform 2 of Nucleolar RNA helicase 2</text>
<text top="392" left="559" width="6" height="13" font="9">4</text>
<text top="392" left="712" width="6" height="13" font="9">2</text>
<text top="406" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="406" left="140" width="343" height="13" font="9">Isoform 2 of Very long‐chain specific acyl‐CoA dehydrogenase, mitochondrial</text>
<text top="406" left="559" width="6" height="13" font="9">4</text>
<text top="406" left="712" width="6" height="13" font="9">2</text>
<text top="420" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="420" left="140" width="179" height="13" font="9">Putative uncharacterized protein DDX56</text>
<text top="420" left="559" width="6" height="13" font="9">4</text>
<text top="420" left="712" width="6" height="13" font="9">2</text>
<text top="434" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="434" left="140" width="152" height="13" font="9">SNW domain‐containing protein 1</text>
<text top="434" left="559" width="6" height="13" font="9">4</text>
<text top="434" left="659" width="59" height="13" font="9">1.333333333</text>
<text top="448" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="448" left="140" width="66" height="13" font="9">43 kDa protein</text>
<text top="448" left="559" width="6" height="13" font="9">4</text>
<text top="448" left="659" width="59" height="13" font="9">0.210526316</text>
<text top="462" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="462" left="140" width="29" height="13" font="9">Erlin‐1</text>
<text top="462" left="559" width="6" height="13" font="9">4</text>
<text top="462" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="476" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="476" left="140" width="181" height="13" font="9">histone‐binding protein RBBP4 isoform c</text>
<text top="476" left="559" width="6" height="13" font="9">4</text>
<text top="476" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="490" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="490" left="140" width="106" height="13" font="9">Isoform 1 of RuvB‐like 1</text>
<text top="490" left="559" width="6" height="13" font="9">4</text>
<text top="490" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="504" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="504" left="140" width="185" height="13" font="9">Leucine‐rich repeat‐containing protein 15</text>
<text top="504" left="559" width="6" height="13" font="9">4</text>
<text top="504" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="518" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="518" left="140" width="203" height="13" font="9">Nuclease‐sensitive element‐binding protein 1</text>
<text top="518" left="559" width="6" height="13" font="9">4</text>
<text top="518" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
</page>
<page number="8" position="absolute" top="0" left="0" height="612" width="792">
<text top="72" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="72" left="140" width="221" height="13" font="9">Trifunctional enzyme subunit beta, mitochondrial</text>
<text top="72" left="559" width="6" height="13" font="9">4</text>
<text top="72" left="712" width="6" height="13" font="9">4</text>
<text top="86" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="86" left="140" width="162" height="13" font="9">ATP‐dependent RNA helicase DDX3X</text>
<text top="86" left="559" width="6" height="13" font="9">3</text>
<text top="86" left="704" width="14" height="13" font="9">1.5</text>
<text top="100" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="100" left="140" width="264" height="13" font="9">ATPase family AAA domain‐containing protein 3A isoform 3</text>
<text top="100" left="559" width="6" height="13" font="9">3</text>
<text top="100" left="692" width="25" height="13" font="9">0.375</text>
<text top="114" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="114" left="140" width="193" height="13" font="9">Isoform 1 of Torsin‐1A‐interacting protein 1</text>
<text top="114" left="559" width="6" height="13" font="9">3</text>
<text top="114" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="128" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="128" left="140" width="263" height="13" font="9">Isoform Short of TATA‐binding protein‐associated factor 2N</text>
<text top="128" left="559" width="6" height="13" font="9">3</text>
<text top="128" left="712" width="6" height="13" font="9">2</text>
<text top="142" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="142" left="140" width="70" height="13" font="9">Pyruvate kinase</text>
<text top="142" left="559" width="6" height="13" font="9">3</text>
<text top="142" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="156" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="156" left="140" width="157" height="13" font="9">60S ribosomal protein L3 isoform b</text>
<text top="156" left="559" width="6" height="13" font="9">3</text>
<text top="156" left="712" width="6" height="13" font="9">3</text>
<text top="170" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="170" left="140" width="27" height="13" font="9">Bystin</text>
<text top="170" left="559" width="6" height="13" font="9">3</text>
<text top="170" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="184" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="184" left="140" width="229" height="13" font="9">Cytochrome b‐c1 complex subunit 2, mitochondrial</text>
<text top="184" left="559" width="6" height="13" font="9">3</text>
<text top="184" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="198" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="198" left="140" width="175" height="13" font="9">Isoform 1 of Core histone macro‐H2A.1</text>
<text top="198" left="559" width="6" height="13" font="9">3</text>
<text top="198" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="211" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="211" left="140" width="175" height="13" font="9">Isoform 3 of Core histone macro‐H2A.1</text>
<text top="211" left="559" width="6" height="13" font="9">3</text>
<text top="211" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="225" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="225" left="140" width="235" height="13" font="9">ornithine aminotransferase, mitochondrial isoform 2</text>
<text top="225" left="559" width="6" height="13" font="9">3</text>
<text top="225" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="239" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="239" left="140" width="193" height="13" font="9">Putative uncharacterized protein HNRNPAB</text>
<text top="239" left="559" width="6" height="13" font="9">3</text>
<text top="239" left="712" width="6" height="13" font="9">3</text>
<text top="253" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="253" left="140" width="214" height="13" font="9">Ribosomal RNA processing protein 1 homolog A</text>
<text top="253" left="559" width="6" height="13" font="9">3</text>
<text top="253" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="267" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="267" left="140" width="65" height="13" font="9">TUBB6 protein</text>
<text top="267" left="559" width="6" height="13" font="9">3</text>
<text top="267" left="659" width="59" height="13" font="9">0.157894737</text>
<text top="281" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="281" left="140" width="66" height="13" font="9">73 kDa protein</text>
<text top="281" left="559" width="6" height="13" font="9">2</text>
<text top="281" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="295" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="295" left="140" width="162" height="13" font="9">Isoform 1 of RNA‐binding protein 14</text>
<text top="295" left="559" width="6" height="13" font="9">2</text>
<text top="295" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="309" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="309" left="140" width="178" height="13" font="9">Isoform 1 of Splicing factor 3B subunit 3</text>
<text top="309" left="559" width="6" height="13" font="9">2</text>
<text top="309" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="323" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="323" left="140" width="42" height="13" font="9">Lamin‐B1</text>
<text top="323" left="559" width="6" height="13" font="9">2</text>
<text top="323" left="659" width="59" height="13" font="9">0.222222222</text>
<text top="337" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="337" left="140" width="250" height="13" font="9">probable ATP‐dependent RNA helicase DDX52 isoform b</text>
<text top="337" left="559" width="6" height="13" font="9">2</text>
<text top="337" left="712" width="6" height="13" font="9">1</text>
<text top="351" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="351" left="140" width="223" height="13" font="9">Replication protein A 70 kDa DNA‐binding subunit</text>
<text top="351" left="559" width="6" height="13" font="9">2</text>
<text top="351" left="704" width="14" height="13" font="9">0.5</text>
<text top="365" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="365" left="140" width="205" height="13" font="9">T‐complex protein 1 subunit gamma isoform c</text>
<text top="365" left="559" width="6" height="13" font="9">2</text>
<text top="365" left="712" width="6" height="13" font="9">1</text>
<text top="379" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="379" left="140" width="249" height="13" font="9">cDNA FLJ53912, highly similar to Zinc finger protein 512</text>
<text top="379" left="559" width="6" height="13" font="9">2</text>
<text top="379" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="392" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="392" left="140" width="167" height="13" font="9">Interleukin enhancer‐binding factor 2</text>
<text top="392" left="559" width="6" height="13" font="9">2</text>
<text top="392" left="712" width="6" height="13" font="9">2</text>
<text top="406" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="406" left="140" width="200" height="13" font="9">Isoform 2 of Polyadenylate‐binding protein 2</text>
<text top="406" left="559" width="6" height="13" font="9">2</text>
<text top="406" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="420" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="420" left="140" width="224" height="13" font="9">Isoform 5 of Interleukin enhancer‐binding factor 3</text>
<text top="420" left="559" width="6" height="13" font="9">2</text>
<text top="420" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="434" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="434" left="140" width="151" height="13" font="9">Phosphoglycerate dehydrogenase</text>
<text top="434" left="559" width="6" height="13" font="9">2</text>
<text top="434" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
<text top="448" left="56" width="65" height="13" font="9">CEBPZ_Band B</text>
<text top="448" left="140" width="177" height="13" font="9">Putative uncharacterized protein KRT34</text>
<text top="448" left="559" width="6" height="13" font="9">2</text>
<text top="448" left="629" width="89" height="13" font="9">NOT IN CONTROL IP</text>
</page>
</pdf2xml>
